Eureka Homestead Bancorp, Inc.
ERKH
$16.50
-$0.50-2.94%
| Weiss Ratings | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.34 | |||
| Price History | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.13% | |||
| 30-Day Total Return | -9.59% | |||
| 60-Day Total Return | 4.18% | |||
| 90-Day Total Return | 17.23% | |||
| Year to Date Total Return | -8.28% | |||
| 1-Year Total Return | -10.76% | |||
| 2-Year Total Return | 8.20% | |||
| 3-Year Total Return | 13.01% | |||
| 5-Year Total Return | 36.59% | |||
| 52-Week High % Change | -10.53% | |||
| 52-Week Low % Change | 28.21% | |||
| Price | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $19.00 | |||
| 52-Week Low Price | $13.26 | |||
| 52-Week Low Price (Date) | Oct 11, 2024 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.89M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.22 | |||
| Earnings Per Share Growth | -325.75% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.58 | |||
| Price/Book (Q) | 0.83 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $16.50 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 863.00K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 504 834 0242 | |||
| Address | 1922 Veterans Memorial Blvd. Metairie, LA 70005 | |||
| Website | www.eurekahomestead.com | |||
| Country | United States | |||
| Year Founded | 1884 | |||
| Profitability | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -5.28% | |||
| Profit Margin | -7.83% | |||
| Management Effectiveness | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 428.00K | |||
| Total Revenue (TTM) | 2.63M | |||
| Revenue Per Share | $3.05 | |||
| Gross Profit (TTM) | 2.63M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -206.00K | |||
| Net Income Avl. to Common (TTM) | -206.00K | |||
| Total Revenue Growth (Q YOY) | -6.09% | |||
| Earnings Growth (Q YOY) | -200.00% | |||
| EPS Diluted (TTM) | -0.22 | |||
| EPS Diluted Growth (Q YOY) | -190.16% | |||
| Balance Sheet | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.75M | |||
| Cash Per Share (Q) | $8.98 | |||
| Total Current Assets (Q) | 8.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 19.21M | |||
| Current Ratio (Q) | 0.108 | |||
| Book Value Per Share (Q) | $20.55 | |||
| Total Assets (Q) | 105.37M | |||
| Total Current Liabilities (Q) | 77.57M | |||
| Total Debt (Q) | 19.28M | |||
| Total Liabilities (Q) | 86.16M | |||
| Total Common Equity (Q) | 19.21M | |||
| Cash Flow | ERKH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
